|
Glucose intolerance
Citations 101-110 of 141 total displayed.
|
Past content
(since Feb 2001):
|
- Scientific Contributions
Insulin Resistance and Hypertension: The Insulin Resistance Atherosclerosis Study
- Mohammed F. Saad, Marian Rewers, Joseph Selby, George Howard, Sujata Jinagouda, Salwa Fahmi, Dan Zaccaro, Richard N. Bergman, Peter J. Savage, and Steven M. Haffner
Hypertension 2004;43:1324-1331; published online before print as doi:10.1161/01.HYP.0000128019.19363.f9
[Abstract]
[Full text]
- Scientific Contributions
Insulin Resistance and Hypertension. The Insulin Resistance Atherosclerosis Study
- Mohammed F. Saad, Marian Rewers, Joseph Selby, George Howard, Sujata Jinagouda, Salwa Fahmi, Dan Zaccaro, Richard N. Bergman, Peter J. Savage, and Steven M. Haffner
Hypertension published May 3, 2004, doi:10.1161/01.HYP.0000128019.19363.f9
[Abstract]
- Scientific Contributions
Adverse Prognostic Significance of New Diabetes in Treated Hypertensive Subjects
- Paolo Verdecchia, Gianpaolo Reboldi, Fabio Angeli, Claudia Borgioni, Roberto Gattobigio, Lucia Filippucci, Silvia Norgiolini, Costanza Bracco, and Carlo Porcellati
Hypertension 2004;43:963-969; published online before print as doi:10.1161/01.HYP.0000125726.92964.ab
[Abstract]
[Full text]
- Scientific Contributions
Glucose-Cholesterol Interaction Magnifies Coronary Heart Disease Risk for Hypertensive Patients
- Hillel W. Cohen, Susan M. Hailpern, and Michael H. Alderman
Hypertension 2004;43:983-987; published online before print as doi:10.1161/01.HYP.0000124918.30897.55
[Abstract]
[Full text]
- Scientific Contributions
Identification of Telmisartan as a Unique Angiotensin II Receptor Antagonist With Selective PPAR Modulating Activity
- Stephen C. Benson, Harrihar A. Pershadsingh, Christopher I. Ho, Amar Chittiboyina, Prashant Desai, Michal Pravenec, Nianning Qi, Jiaming Wang, Mitchell A. Avery, and Theodore W. Kurtz
Hypertension 2004;43:993-1002; published online before print as doi:10.1161/01.HYP.0000123072.34629.57
[Abstract]
[Full text]
- Scientific Contributions
Angiotensin II Type-1 Receptor Blocker Valsartan Enhances Insulin Sensitivity in Skeletal Muscles of Diabetic Mice
- Tetsuya Shiuchi, Masaru Iwai, Huan-Sheng Li, Lan Wu, Li-Juan Min, Jian-Mei Li, Midori Okumura, Tai-Xing Cui, and Masatsugu Horiuchi
Hypertension 2004;43:1003-1010; published online before print as doi:10.1161/01.HYP.0000125142.41703.64
[Abstract]
[Full text]
- Scientific Contributions
Hypertension and Insulin Resistance Are Not Directly Related in Obese Dogs
- Albert P. Rocchini, John Q. Yang, and Amy Gokee
Hypertension 2004;43:1011-1016; published online before print as doi:10.1161/01.HYP.0000123073.48855.e9
[Abstract]
[Full text]
- Scientific Contributions
Adverse Prognostic Significance of New Diabetes in Treated Hypertensive Subjects
- Paolo Verdecchia, Gianpaolo Reboldi, Fabio Angeli, Claudia Borgioni, Roberto Gattobigio, Lucia Filippucci, Silvia Norgiolini, Costanza Bracco, and Carlo Porcellati
Hypertension published March 22, 2004, doi:10.1161/01.HYP.0000125726.92964.ab
[Abstract]
- Scientific Contributions
Angiotensin II Type-1 Receptor Blocker Valsartan Enhances Insulin Sensitivity in Skeletal Muscles of Diabetic Mice
- Tetsuya Shiuchi, Masaru Iwai, Huan-Sheng Li, Lan Wu, Li-Juan Min, Jian-Mei Li, Midori Okumura, Tai-Xing Cui, and Masatsugu Horiuchi
Hypertension published March 22, 2004, doi:10.1161/01.HYP.0000125142.41703.64
[Abstract]
- Scientific Contributions
Glucose-Cholesterol Interaction Magnifies Coronary Heart Disease Risk for Hypertensive Patients
- Hillel W. Cohen, Susan M. Hailpern, and Michael H. Alderman
Hypertension published March 22, 2004, doi:10.1161/01.HYP.0000124918.30897.55
[Abstract]
|
|